Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
kabonk's Profile
Displaying 101-150 of 238 result(s).
CYDY CytoDyn Inc
06/30/2021 11:56:00 PM
Thanks. It's hard to imagine how LL (1)
CYDY CytoDyn Inc
06/30/2021 2:52:56 PM
Sorry, the proposed reason for non- (2)
CYDY CytoDyn Inc
06/30/2021 2:24:52 PM
The first longhauler's index diagno (2)
CYDY CytoDyn Inc
06/21/2021 10:46:19 AM
How is clinical meaningfulness defi
CYDY CytoDyn Inc
06/21/2021 10:41:28 AM
Study was not designed to show any
CYDY CytoDyn Inc
05/17/2021 7:04:55 PM
FDA needs a little more. BTW, whoev (16)
CYDY CytoDyn Inc
05/17/2021 6:14:28 PM
FDA did this I believe because they (2)
CYDY CytoDyn Inc
04/30/2021 10:34:35 AM
Mesoblast MSC results at 60 days in (11)
CYDY CytoDyn Inc
04/28/2021 11:58:10 AM
Ha, speaking of pet meds, apparentl (2)
CYDY CytoDyn Inc
04/28/2021 11:34:23 AM
Just saw this prior PR talking abou (5)
CYDY CytoDyn Inc
04/27/2021 11:47:44 PM
OK. Reading your post history you a (1)
CYDY CytoDyn Inc
04/27/2021 11:30:22 PM
The original claim was that CYDY wa (2)
CYDY CytoDyn Inc
04/27/2021 4:38:21 PM
Imaging is of course part of the mT (2)
CYDY CytoDyn Inc
04/22/2021 3:25:46 PM
True, or people can see that since (3)
CYDY CytoDyn Inc
04/21/2021 10:28:33 PM
Hah, I have a feeling NP was confus (4)
CYDY CytoDyn Inc
04/21/2021 8:03:38 PM
Can't run the trial without doing t (3)
CYDY CytoDyn Inc
04/21/2021 7:36:18 PM
Really? CCR5 tropism is an inclusio (3)
CYDY CytoDyn Inc
04/17/2021 9:20:12 PM
Marketed commercially means adverti (4)
CYDY CytoDyn Inc
04/11/2021 8:21:55 PM
Agree if SA variant more transmissa (1)
CYDY CytoDyn Inc
04/11/2021 6:33:53 PM
More likely that the vaccine protec
CYDY CytoDyn Inc
04/07/2021 5:33:19 PM
Not sure on the why FDA hasn't give (5)
CYDY CytoDyn Inc
04/05/2021 9:41:53 PM
Jakafi placebo mortality 70%? LL ha (2)
CYDY CytoDyn Inc
04/05/2021 1:32:52 PM
Innovation Pharm (IPIX) had the dos (3)
CYDY CytoDyn Inc
03/30/2021 10:12:38 AM
Would love to see LL CD12 outcomes (1)
CYDY CytoDyn Inc
03/29/2021 4:10:42 AM
Interesting. And confusing .. like (3)
CYDY CytoDyn Inc
03/28/2021 11:09:03 PM
Can you point us to any longhaulers (2)
CYDY CytoDyn Inc
03/26/2021 12:01:29 AM
He is an interesting, bright, well (6)
CYDY CytoDyn Inc
03/25/2021 11:25:11 PM
Right, he is not doing a study, but (2)
CYDY CytoDyn Inc
03/24/2021 4:02:01 PM
Agree it would be great to hear mor (1)
CYDY CytoDyn Inc
03/24/2021 2:15:14 PM
At least it seems like NP must be m (3)
CYDY CytoDyn Inc
03/22/2021 2:14:29 PM
Isn't this just the OLE they announ (3)
CYDY CytoDyn Inc
03/19/2021 7:00:17 PM
28D mortality overall (mITT) N=384 (1)
CYDY CytoDyn Inc
03/19/2021 10:33:33 AM
Good point. Lots of things to consi (1)
CYDY CytoDyn Inc
03/18/2021 3:03:16 PM
"Conditional" EUA could be redundan (2)
CYDY CytoDyn Inc
03/08/2021 11:26:19 AM
Agree, small numbers makes random s (3)
CYDY CytoDyn Inc
03/08/2021 11:16:53 AM
Good writeup, but made the mistake (6)
CYDY CytoDyn Inc
03/07/2021 8:32:23 PM
Talking about this from Sat. PR: "1 (2)
CYDY CytoDyn Inc
03/07/2021 5:24:40 PM
I disagree. I think both population (3)
CYDY CytoDyn Inc
03/06/2021 10:36:01 PM
I think critical = ACTT Covid scale (2)
CYDY CytoDyn Inc
03/06/2021 9:43:26 PM
NP confirms based on FDA feedback o (3)
CYDY CytoDyn Inc
03/05/2021 11:31:09 PM
Yes, stupidly was thinking 11% was
CYDY CytoDyn Inc
03/05/2021 9:54:39 PM
Haha, I believe you are right! Here (4)
CYDY CytoDyn Inc
03/05/2021 7:14:28 PM
And 24% is apparently absolute redu (1)
CYDY CytoDyn Inc
03/05/2021 6:28:53 PM
Could be, and hope so. Just wonderi (2)
CYDY CytoDyn Inc
03/05/2021 5:55:02 PM
Unfortunately only in 62 critically
CYDY CytoDyn Inc
03/04/2021 7:28:16 PM
On May 11, Amarex achieved approval
CYDY CytoDyn Inc
03/04/2021 11:58:18 AM
Thanks for the nice, thought provok (8)
CYDY CytoDyn Inc
03/02/2021 4:07:18 PM
Agree it's a goofy name. Will see i (12)
CYDY CytoDyn Inc
03/02/2021 3:23:36 PM
We know our long-hauler's study is (5)
CYDY CytoDyn Inc
02/26/2021 10:20:01 PM
My bad .. misread that graph. Busy (5)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Reviving Lost Crypto: The Journey of a Bitcoin Recovery Expert
  • Brittany Force Achieves Historic NHRA Speed Record of 343.16 MPH
  • Reza Pahlavi Reports Surge in Support from Iranian Defectors
  • Sling Pilot Academy Joins Forces with Sallie Mae for Financing
  • Expansion of Precision Global Corporation with CubeSmart Partnership
  • Precision Global Corporation and CubeSmart Join Forces for Growth
  • Trump's Administration Investments: A Long-Term Shift in Strategy
  • Robert Kiyosaki Compares ETFs to Pictures of Guns, Advocates for Real Assets
  • Justice Department's Decision Sparks Controversy Over Attorney Dismissal
  • Elon Musk's Surprising View on AI and Rising Birth Rates
  • How the Wealthy Diversify: Watches, Diamonds, and the Rise of Collectible Assets
  • Independent Voter Sentiment Shifts Significantly for Trump
  • Massive Bitcoin Movement Shakes Crypto Markets After Years
  • Senator Lummis Advocates Bitcoin: A Vision for Economic Freedom
  • TDECU and C.J. Stroud Unite to Promote Financial Literacy
  • Dogecoin's Potential Surge: A Historic Buying Opportunity
  • Revolutionizing Startup Software Development with AI Solutions
  • Secure Your Rights: Join WAMCO Class Action Lawsuit Today
  • GeneDx Holdings Corp: Investigating Investor Rights Concerns
  • Rosen Law Firm Invites Investors in Rocket Pharmaceuticals to Act
  • Donald Trump's Scottish Visit: Golf, Legacy, and Diplomacy
  • From Credit Dips to Dividend Tips: When an Online Loan Makes Sense
  • Understanding the Pink Salt Trend and Its Health Implications
  • WeRide and Chery Join Forces to Launch Global Robotaxi Services
  • Investor Challenges Tencent Music's Acquisition of Ximalaya Inc.
  • How To Choose The Right Software Solution For Your Business?
  • American Progress: President Trump's Administration Updates
  • Unlock Potential with BexBack's 100x Crypto Leverage
  • WeRide's New Robotaxi Permit: A Step Towards Smart Mobility
  • Jamie Dimon Reflects on Dismissal and Family's Support
  • America's Journey to Stardom: Insights from President Trump
  • Biohaven Securities Fraud Lawsuit: Join the Action Today
  • Injury Lawsuits Can Sink More Than Morale—They Can Tank Your Assets
  • Exploring America's Hidden Mineral Rush Beneath the Surface
  • Key Developments for Rocket Pharmaceuticals Investors
  • Discover the KatuChef Cutting Board: Kitchen Innovation Redefined
  • Neogen Corporation Faces Class Action Amid Financial Challenges
  • Explore TWOPAGES' Trendsetting Insights for Home Décor in 2025
  • Celebrating Coinchange's Growth: A Journey to Institutional Finance
  • Unlocking the Future: The Final Hours of Bitcoin Swift Presale
  • Bitcoin Swift Set to Conclude Stage 1 Presale with Unique Features
  • RxSight, Inc. Investors Have Chance to Lead Class Action Lawsuit
  • Anthony Scaramucci Commends Trump's Political Comeback and Insights
  • Investigation of National Grid plc Sparks Interest Among Investors
  • Transforming Spiritual Guidance: Experience Free Psychic Readings
  • Understanding Audifort: The Natural Hearing Solution for 2025
  • Investors' Hidden Gems: Stocks Making Waves This Week
  • Vestis Corporation Investors Urged to Join Securities Class Action
  • Pony AI Secures Permit for Driverless Robotaxi Services Launch
  • Market Focus: T-Mobile, LendingTree, and Molina Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site